Merck KGaA (OTCMKTS:MKKGY – Get Free Report) shares hit a new 52-week low during mid-day trading on Thursday . The company traded as low as $28.96 and last traded at $29.08, with a volume of 139382 shares trading hands. The stock had previously closed at $29.31.
Analyst Upgrades and Downgrades
Separately, The Goldman Sachs Group assumed coverage on Merck KGaA in a research note on Thursday, September 19th. They issued a “buy” rating on the stock.
Get Our Latest Stock Analysis on Merck KGaA
Merck KGaA Price Performance
Merck KGaA Company Profile
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Read More
- Five stocks we like better than Merck KGaA
- About the Markup Calculator
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
- How Investors Can Find the Best Cheap Dividend Stocks
- MarketBeat Week in Review – 11/18 – 11/22
- Manufacturing Stocks Investing
- 2 Finance Stocks With Competitive Advantages You Can’t Ignore
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.